TABLE 2. Donor features according to the result of the viability assessment and outcome after transplant.
| Donor characteristics and graft histology | Discarded | Transplanted | p value | Functioning | PNF | p value |
|---|---|---|---|---|---|---|
| n | 4 | 10 | 8 | 2 | ||
| Donor type | 1.00 | 1.00 | ||||
| DBD | 4 (100) | 9 (90) | 7 (88) | 2 (100) | ||
| Category 3 DCD | 0 (0) | 1 (10) | 1 (12) | 0 (0) | ||
| Age, years | 66 (60, 71) | 61 (50, 71) | 0.62 | 55 (50, 66) | 70 (69, 71) | 0.30 |
| BMI | 35 (34, 35) | 35 (28, 36) | 1.00 | 35 (32, 36) | 40 (33, 47) | 0.60 |
| ITU stay, days | 1.5 (1.0, 3.0) | 3.0 (2.0, 5.8) | 0.20 | 2.5 (2.0, 5.8) | 4.5 (3.8, 5.2) | 0.51 |
| Sodium, mmol/L | 147 (146, 150) | 146 (144, 157) | 0.78 | 147 (145, 160) | 144 (144, 145) | 0.36 |
| AST, IU/L | 197 (98, 616) | 74 (33, 113) | 0.18 | 88 (58, 139) | 36 (33, 38) | 0.30 |
| ALT, IU/L | 141 (57, 443) | 48 (30, 121) | 0.16 | 82 (34, 125) | 33 (30, 37) | 0.30 |
| GGT, IU/L | 88 (42, 142) | 74 (35, 146) | 0.72 | 74 (33, 132) | 151 (95, 206) | 0.60 |
| Creatinine, mg/dl | 1.5 (1.3, 2.0) | 1.7 (0.9, 2.5) | 0.83 | 2.2 (1.0, 2.7) | 1.0 (0.8, 1.2) | 0.30 |
| Cold ischemia time, min | 337 (311, 407) | 244 (240, 326) | 0.14 | 244 (229, 319) | 353 (297, 409) | 0.36 |
| NMP time, min | 284 (250, 306.5) | 332 (300, 374) | 0.16 | 302 (285, 365) | 425 (392, 457) | 0.15 |
| Macrosteatosis, % | 47 (41, 52) | 40 (31, 57) | 0.83 | 40 (34, 52) | 55 (42, 67) | 1.00 |
| Microsteatosis, % | 10 (5, 25) | 20 (2, 27) | 0.86 | 20 (7, 30) | 10 (5, 15) | 0.42 |
Note: Data are presented as count (percentage) or median (IQR).
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; DBD, donation after brain death; DCD, donation after circulatory death; GGT, gamma‐glutamyltransferase; IQR, interquartile range; ITU, intensive therapy unit; NMP, normothermic machine perfusion; PNF, primary nonfunction.